Skip to main content

02.08.2024 | original article

Chronic kidney disease is associated with increased 30-day mortality and morbidities after esophagectomy: a propensity score matched study

verfasst von: Renxi Li

Erschienen in: European Surgery

Einloggen, um Zugang zu erhalten

Summary

Background

Chronic kidney disease (CKD) is one of the most prevalent comorbid conditions in the US. While prior studies have established a correlation between CKD and increased mortality and complications in surgery, its impact on esophagectomy outcomes remains underexplored. This study aimed to assess the effect of CKD on the 30-day outcomes of esophagectomy using data from a national registry.

Methods

The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) esophagectomy-targeted database was used in this retrospective study. The period considered was from 2016 to 2022. Patients with CKD were selected based on an estimated glomerular filtration rate (eGFR) ≤ 60 mL/min/1.73m2. A 1:2 propensity score matching was applied to CKD and non-CKD patients for demographics, baseline characteristics, neoadjuvant therapy, surgical approaches, tumor diagnosis, and staging of the malignancy. The 30-day postoperative outcomes were then compared.

Results

There were 655 (8.30%) and 7232 patients with and without CKD who underwent esophagectomy, respectively, whereby 1310 non-CKD patients were matched to all CKD patients. After propensity score matching, CKD patients had higher mortality (6.72% vs. 3.44%, p < 0.01), pulmonary complications (28.85% vs. 23.21%, p = 0.01), renal complications (7.18% vs. 2.44%, p < 0.01), sepsis (16.03% vs. 12.14%, p = 0.02), and bleeding requiring transfusion (16.64% vs. 12.06%, p = 0.01).

Conclusion

CKD can be an independent risk factor for adverse outcomes following esophagectomy. This underscores the importance of thorough preoperative risk stratification and the need for targeted management strategies for patients with CKD to potentially improve their surgical outcomes.
Literatur
2.
Zurück zum Zitat Rodriguez GM, DePuy D, Aljehani M, Bien J, Lee JSH, Wang DH, et al. Trends in Epidemiology of Esophageal Cancer in the US, 1975–2018. JAMA Netw Open. 2023;2023(6):e2329497.CrossRef Rodriguez GM, DePuy D, Aljehani M, Bien J, Lee JSH, Wang DH, et al. Trends in Epidemiology of Esophageal Cancer in the US, 1975–2018. JAMA Netw Open. 2023;2023(6):e2329497.CrossRef
3.
Zurück zum Zitat Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin. 2022;2022(72):7–33.CrossRef Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin. 2022;2022(72):7–33.CrossRef
4.
Zurück zum Zitat Wang Q‑L, Xie S‑H, Li W‑T, Lagergren J. Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis. J Natl Cancer Inst. 2017;109:djx115.CrossRef Wang Q‑L, Xie S‑H, Li W‑T, Lagergren J. Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis. J Natl Cancer Inst. 2017;109:djx115.CrossRef
5.
Zurück zum Zitat Heid CA, Khoury MK, Thornton MA, Geoffrion TR, De Hoyos AL. Risk factors for non-home discharge following Esophagectomy for neoplastic disease. Ann Thorac Surg. 2021;111:1118–24.CrossRefPubMed Heid CA, Khoury MK, Thornton MA, Geoffrion TR, De Hoyos AL. Risk factors for non-home discharge following Esophagectomy for neoplastic disease. Ann Thorac Surg. 2021;111:1118–24.CrossRefPubMed
6.
Zurück zum Zitat Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338–44.CrossRefPubMedPubMedCentral Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338–44.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Reeh M, Metze J, Uzunoglu FG, Nentwich M, Ghadban T, Wellner U, et al. The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer. Medicine. 2016;95:e2724.CrossRefPubMedPubMedCentral Reeh M, Metze J, Uzunoglu FG, Nentwich M, Ghadban T, Wellner U, et al. The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer. Medicine. 2016;95:e2724.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Mathew A, Devereaux PJ, O’Hare A, Tonelli M, Thiessen-Philbrook H, Nevis IFP, et al. Chronic kidney disease and postoperative mortality: A systematic review and meta-analysis. Kidney Int. 2008;73:1069–81.CrossRefPubMed Mathew A, Devereaux PJ, O’Hare A, Tonelli M, Thiessen-Philbrook H, Nevis IFP, et al. Chronic kidney disease and postoperative mortality: A systematic review and meta-analysis. Kidney Int. 2008;73:1069–81.CrossRefPubMed
10.
Zurück zum Zitat Sharma K, Slawski B. Renal disease and the surgical patient: Minimizing the impact. Cleve Clin J Med. 2018;85:559–67.CrossRefPubMed Sharma K, Slawski B. Renal disease and the surgical patient: Minimizing the impact. Cleve Clin J Med. 2018;85:559–67.CrossRefPubMed
11.
Zurück zum Zitat Zaza M, Gaur P, Chan EY, Kim MP. Minimally invasive esophagectomy in a patient with end-stage renal disease. BMJ Case Rep. 2016;2016:bcr2016214551.CrossRefPubMedPubMedCentral Zaza M, Gaur P, Chan EY, Kim MP. Minimally invasive esophagectomy in a patient with end-stage renal disease. BMJ Case Rep. 2016;2016:bcr2016214551.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Urabe M, Ueno M, Yago A, Shimoyama H, Ohkura Y, Haruta S, et al. Esophageal Cancer Surgery in Dialyzed Patients: A Single Institution Case Series. Ann Thorac Cardiovasc Surg. 2022;28:366–70.CrossRefPubMed Urabe M, Ueno M, Yago A, Shimoyama H, Ohkura Y, Haruta S, et al. Esophageal Cancer Surgery in Dialyzed Patients: A Single Institution Case Series. Ann Thorac Cardiovasc Surg. 2022;28:366–70.CrossRefPubMed
13.
Zurück zum Zitat Xiao H, Shao X, Gao P, Zou H, Zhang X. Metabolic Syndrome Components and Chronic Kidney Disease in a Community Population Aged 40 Years and Older in Southern China: A Cross-Sectional Study. DMSO. 2022;15:839–48.CrossRef Xiao H, Shao X, Gao P, Zou H, Zhang X. Metabolic Syndrome Components and Chronic Kidney Disease in a Community Population Aged 40 Years and Older in Southern China: A Cross-Sectional Study. DMSO. 2022;15:839–48.CrossRef
14.
Zurück zum Zitat Norris P, Gow J, Arthur T, Conway A, Fleming FJ, Ralph N. Metabolic syndrome and surgical complications: a systematic review and meta-analysis of 13 million individuals. Int J Surg. 2024;110:541–53.CrossRefPubMed Norris P, Gow J, Arthur T, Conway A, Fleming FJ, Ralph N. Metabolic syndrome and surgical complications: a systematic review and meta-analysis of 13 million individuals. Int J Surg. 2024;110:541–53.CrossRefPubMed
15.
Zurück zum Zitat Olyaei AJ, Steffl JL. A Quantitative Approach to Drug Dosing in Chronic Kidney Disease. Blood Purif. 2011;31:138–45.CrossRefPubMed Olyaei AJ, Steffl JL. A Quantitative Approach to Drug Dosing in Chronic Kidney Disease. Blood Purif. 2011;31:138–45.CrossRefPubMed
17.
Zurück zum Zitat Baaten CCFMJ, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H. Platelet Function in CKD: A Systematic Review and Meta-Analysis. J Am Soc Nephrol. 2021;32:1583–98.CrossRefPubMedPubMedCentral Baaten CCFMJ, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H. Platelet Function in CKD: A Systematic Review and Meta-Analysis. J Am Soc Nephrol. 2021;32:1583–98.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Jain N, Corken AL, Kumar A, Davis CL, Ware J, Arthur JM. Role of Platelets in Chronic Kidney Disease. J Am Soc Nephrol. 2021;32:1551–8.CrossRefPubMedPubMedCentral Jain N, Corken AL, Kumar A, Davis CL, Ware J, Arthur JM. Role of Platelets in Chronic Kidney Disease. J Am Soc Nephrol. 2021;32:1551–8.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Espi M, Koppe L, Fouque D, Thaunat O. Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells. Toxins. 2020;12:300.CrossRefPubMedPubMedCentral Espi M, Koppe L, Fouque D, Thaunat O. Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells. Toxins. 2020;12:300.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Syed-Ahmed M, Narayanan M. Immune Dysfunction and Risk of Infection in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2019;26:8–15.CrossRefPubMed Syed-Ahmed M, Narayanan M. Immune Dysfunction and Risk of Infection in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2019;26:8–15.CrossRefPubMed
Metadaten
Titel
Chronic kidney disease is associated with increased 30-day mortality and morbidities after esophagectomy: a propensity score matched study
verfasst von
Renxi Li
Publikationsdatum
02.08.2024
Verlag
Springer Vienna
Erschienen in
European Surgery
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-024-00835-0